期刊文献+

药品不良反应监测数据库信息标准化建设 被引量:4

Standardization Monitoring Database Information of Adverse Drug Reaction
下载PDF
导出
摘要 目的:促进广东省药品不良反应自发呈报系统数据库的信息标准化建设,对2002年4月28日~2007年7月10日收集的42 255条数据进行规范化整理。方法:结合第15版新编药物学与MCDEX药物临床信息参考(2006).对数据库中的6万多条的药物通用名称进行规范化整理。结合WHO的不良反应术语集和ICD-10疾病系统分类。规整42 255条药品不良反应记录。结果:建立了5 407个药物通用名称规则名,形成4 031个药物通用名称标准名。建立了8 715个不良事件名称规则名。形成2 332个不良事件名称标准名。建立的规则库能自动完成新入库病例的80%的规范化工作。结论:数据标准化将不规范的习惯用语转化成标准化信息,为数据利用如信号检测和数据挖掘提供了基础。 Objective: To promote the information standardization of adverse drug reaction database of spontaneous reporting system in Guangdong, and to normalize the database including 42 255 records collected from 28 April 2002 to 10 July 2007. Method: Over 60 000 genetic drug names were standardized based on New Pharmacology( 15th edition) and MCDEX Clinical Drug Reference( 2006 ). 42 255 records of adverse drug reaction name were normalized with the WHO Adverse Reaction Terminology and International Classification of Diseases-Ten Revision. Result: 5 407 rules of generic drug name and 4 031 standard drug names were created. 8 715 rules of adverse event name and 2 332 standard names of adverse event were established. The rule database was capable of automatic completion 80% of the standardization work of the new cases. Conclusion: The data standardization translated the habit name to standardized information, and provided the foundation for the reuse of data such as signal detection and data mining.
出处 《药物流行病学杂志》 CAS 2008年第2期118-120,128,共4页 Chinese Journal of Pharmacoepidemiology
关键词 自发呈报系统 标准化 药物通用名称 药品不良反应 Spontaneous reporting system Standardization Generic drug name Adverse drug reaction
  • 相关文献

参考文献9

二级参考文献23

  • 1黄瑾,王卓,徐慧欣.第二军医大学长海医院2003年度229例药品不良反应报告分析[J].药学服务与研究,2005,5(1):69-71. 被引量:15
  • 2Lapeyre M, Gary J, Machelard- Roumagnac M,et al. Incidence and cost of adverse drug reactions in a French cancer institute[J]. Eur J Clin Pharmacol,1997,53 (1):19.
  • 3Society of Health-System Pharmacists. ASHP guidelines on adverse drug reaction monitoring and reporting[J]. Am J Health-Syst Pharm, 1995, 52:417.
  • 4国家药品不良反应监测信息网络系统正式开通[J].药物流行病学杂志,2001,10(3):130-130.
  • 5BALDWIN J.Terminology for reporting adverse events updated[J].J Natl CancerInst,2003,95(15):1103-1104.
  • 6EDWARDS P R,ARONSON J K.Adverse drug reactions:definitions,diagnosis,and management[J].Lancet,2000,356(9237):1255-1259.
  • 7周海钧 安敏霞.人用药品注册技术规范国际协调会(ICH)—信息标准化[J].中国药学杂志,1997,32(2):118-119.
  • 8佚名."国家药物不良反应监察信息网络"第一次专家论证会会议纪要[EB/OL].北京:中国药品生物制品检定所,2001-07-06[2005-06-15].http://www.nicpbp.org.cn /SHW/nicpbp.nsf/alreadytgdoc/669E7841D0FB11F148256 A81001CC561? opendocument.
  • 9HUBBARD W K.Electronic reporting of postmarketing adverse drug reactions; request for comments[EB/OL].Food and Drug Administration,1998-10-06[2005-06-23].http://www.fda.gov/cder/regulatory/ersr/electron.htm.
  • 10BOUSQUET C,LAGIER G,LILLO-Le LOUET A,et al.Appraisal of the MedDRA conceptual structure for describing and grouping adverse drug reactions[J].Drug Saf,2005,28(1):19-34.

共引文献39

同被引文献26

引证文献4

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部